The investigators prepared a novel tranexamic acid (TXA) study designed to estimate the
quantity of blood loss in patients undergoing abdominoplasty surgery. This study aims to
quantify blood loss during abdominoplasty with and without TXA. The central hypothesis is
that TXA administration reduces blood loss and fibrinolysis in patients undergoing
abdominoplasty surgery.